Atosiban does not improve neonatal outcomes in threatened preterm births between 30-34 weeks
1. Perinatal mortality and neonatal morbidity were comparable between the atosiban and placebo groups. 2. Maternal adverse events were similar ...
1. Perinatal mortality and neonatal morbidity were comparable between the atosiban and placebo groups. 2. Maternal adverse events were similar ...
1. Neonatal morbidity rate was comparable between the continuous oxytocin and discontinuous oxytocin groups. 2. There was no significant difference ...
1. In a population-based study based in Southern California, the risk of autism spectrum disorder (ASD) in children was increased ...
1. Intranasal oxytocin was shown not to impact social interaction scores in children and adolescents with autism spectrum disorder (ASD). ...
1. In women undergoing active labour, discontinuation of oxytocin was associated with a slightly higher risk of caesarean section compared ...
1. Compared to sequential use, simultaneous use of oxytocin and a foley balloon for cervical ripening was associated with a ...
1. Administration of oxytocin to a monogenic mouse model of autism improved social interactions 2. Oxytocin treatment during the developmental ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.